Andrew Schwendenman - Chief Accounting Officer at Replimune Group, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Andrew Schwendenman - trading volume in the past year for Replimune Group, Inc.

Holdings reported by Andrew Schwendenman for Replimune Group, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 38,238 $247 K $6.47 May 16, 2024 Direct
Employee Stock Option (right to buy) 53,325 Apr 1, 2024 Direct Common Stock

Transactions reported by Andrew Schwendenman for Replimune Group, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership